col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


145 Results       Page 1

 [1] 
American Society for Clinical Investigation: JCI Insight
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―21 Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections Kevin J. Selva, Pradhipa Ramanathan, Ebene R. Haycroft, Arnold Reynaldi, Deborah Cromer, Chee Wah Tan, et al. (+12)
2 [GO] 2023―Sep―12 Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses Brianna M. Doratt, Suhas Sureshchandra, Heather True, Monica Rincon, Nicole E. Marshall, Ilhem Messaoudi
3 [GO] 2023―Aug―21 Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia Allison C. Billi, Rachael Wasikowski, Feiyang Ma, Srilakshmi Yalavarthi, Claire K. Hoy, Yu Zuo, et al. (+15)
4 [GO] 2023―Aug―21 Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination Hiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, Nikhil Lele, Nicholas C. Buitrago-Pocasangre, Rachel Lutz, et al. (+17)
5 [GO] 2023―Jul―25 Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection Juliana Gonçalves, Magda Melro, Marta Alenquer, Catarina Araújo, Júlia Castro-Neves, Daniela Amaral-Silva, et al. (+7)
6 [GO] 2023―Jun―20 Anti-S1 and S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2 Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, Keeley M. Hatfield, Danielle P. Ings, Debbie Harnum, et al. (+3)
7 [GO] 2023―Jun―20 Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies Samuel D Klebanoff, Lauren B. Rodda, Chihiro Morishima, Mark H. Wener, Yevgeniy Yuzefpolskiy, Estelle Bettelli, et al. (+4)
8 [GO] 2023―Jun―01 Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion Joseph H. Lubin, Christopher Markosian, D. Balamurugan, Minh T. Ma, Chih-Hsiung Chen, Dongfang Liu, et al. (+4)
9 [GO] 2023―May―30 Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics Matteo Broketa, Aurélien Sokal, Michael Mor, Pablo Canales-Herrerias, Angga Perima, Annalisa Meola, et al. (+15)
10 [GO] 2023―May―25 A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection Prashant Dogra, Carmine Schiavone, Zhihui Wang, Javier Ruiz-Ramírez, Sergio Caserta, Daniela I. Staquicini, et al. (+6)
11 [GO] 2023―May―21 Marked elevations in lung and plasma ceramide in COVID-19 linked to microvascular injury Irina Petrache, Elisabet Pujadas, Aditya Ganju, Karina A. Serban, Alexander Borowiec, Beatrice Babbs, et al. (+8)
12 [GO] 2023―May―09 T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, et al. (+12)
13 [GO] 2023―Apr―11 Cytokine storm based mechanisms for extra-pulmonary manifestations of SARS-CoV-2 infection Maria Del Nogal Avila, Ranjan Das, Joubert B. Kharlyngdoh, Eduardo Molina-Jijon, Hector Donoro-Blazquez, Stéphanie Gambut, et al. (+9)
14 [GO] 2023―Apr―09 Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations Jennifer R. Habel, Brendon Y. Chua, Lukasz Kedzierski, Kevin J. Selva, Timon Damelang, Ebene R. Haycroft, et al. (+48)
15 [GO] 2023―Apr―09 Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal model Takuya Tada, Ju-Yi Peng, Belinda M. Dcosta, Nathaniel R. Landau
16 [GO] 2023―Mar―07 Short- and long-term T cell and antibody responses following Dexamethasone treatment in COVID-19 Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica Cristianzano, Kirsten A. Eberhardt, Paula Stubbemann, et al. (+14)
17 [GO] 2023―Mar―02 COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response John F. McDyer, Mahzad Azimpouran, Valerie L. Durkalski-Mauldin, Robert G. Clevenger, Sharon D. Yeatts, Xutao Deng, et al. (+13)
18 [GO] 2023―Feb―20 Impact of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV Samuel R. Schnittman, Wonyeong Jung, Kathleen V. Fitch, Markella V. Zanni, Sara McCallum, Jessica Shih-Lu Lee, et al. (+16)
19 [GO] 2023―Feb―07 A specific molecular signature in SARS-CoV-2 infected kidney biopsies Pierre Isnard, Paul Vergnaud, Serge Garbay, Matthieu Jamme, Maeva Eloudzeri, Alexandre Karras, et al. (+17)
20 [GO] 2023―Feb―07 Selective suppression of de novo SARS-CoV2 vaccine antibody responses in cancer patients on B cell-targeted therapy Joseph H. Azar, John P. Evans, Madison H. Sikorski, Karthik B. Chakravarthy, Selah McKenney, Ian Carmody, et al. (+23)
21 [GO] 2023―Jan―26 An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants Timothy A. Bates, Hans C. Leier, Savannah K. McBride, Devin Schoen, Zoe L. Lyski, David D. Xthona Lee, et al. (+3)
22 [GO] 2023―Jan―09 Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection Qian Li, Kadambari Vijaykumar, Scott E. Phillips, Shah S. Hussain, Nha V. Huynh, Courtney M. Fernandez-Petty, et al. (+20)
23 [GO] 2022―Dec―27 Combined molnupiravir-nirmatrelvir treatment improves effect on SARS-CoV-2 in Macaques Kyle Rosenke, Matthew C. Lewis, Friederike Feldmann, Eric Bohrnsen, Benjamin Schwarz, Atsushi Okumura, et al. (+8)
24 [GO] 2022―Dec―06 Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury Amy R. Cross, Carlos E. de Andrea, María Villalba-Esparza, Manuel F. Landecho, Lucia Cerundolo, Praveen Weeratunga, et al. (+10)
25 [GO] 2022―Nov―29 Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen specific clones Lydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, Nimitha R. Mathew, Daniel J. Sheward, Susannah Leach, et al. (+10)
26 [GO] 2022―Nov―21 Severe acute respiratory disease in American mink experimentally infected with SARS-CoV-2 Danielle R. Adney, Jamie Lovaglio, Jonathan E. Schulz, Claude Kwe Yinda, Victoria A. Avanzato, Elaine Haddock, et al. (+16)
27 [GO] 2022―Nov―15 Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses Sydney I. Ramirez, Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji, et al. (+13)
28 [GO] 2022―Nov―15 SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways Abhishek Kumar Verma, Jian Zheng, David K. Meyerholz, Stanley Perlman
29 [GO] 2022―Oct―09 Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant Michael S. Seaman, Mark J. Siedner, Julie Boucau, Christy L. Lavine, Fadi Ghantous, May Y. Liew, et al. (+23)
30 [GO] 2022―Sep―22 Lower SARS-CoV-2 specific humoral immunity in People Living with HIV-1 recovered from non-hospitalized COVID-19 Daniel J. Schuster, Shelly Karuna, Caroline Brackett, Martina S. Wesley, Shuying S. Li, Nathan Eisel, et al. (+18)
31 [GO] 2022―Sep―21 Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2 Worarat Chaisawangwong, Hanzhi Wang, Theodore Kouo, Sebastian F. Salathe, Ariel Isser, Joan Glick Bieler, et al. (+8)
32 [GO] 2022―Sep―21 Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling Leila B. Giron, Michael J. Peluso, Jianyi Ding, Grace Kenny, Netanel F. Zilberstein, Jane Koshy, et al. (+23)
33 [GO] 2022―Sep―01 SARS-CoV-2 reinfections during the Delta and Omicron waves C. Paul Morris, Raghda E. Eldesouki, Amary Fall, David C. Gaston, Julie M. Norton, Nicholas D. Gallagher, et al. (+4)
34 [GO] 2022―Aug―09 Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people Joana Vitallé, Alberto Pérez-Gómez, Francisco José Ostos, Carmen Gasca-Capote, Maria Reyes Jiménez-Leon, Sara Bachiller, et al. (+7)
35 [GO] 2022―Jul―19 Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19 Carmelo Carmona-Rivera, Yu Zhang, Kerry Dobbs, Tovah E. Markowitz, Clifton L. Dalgard, Andrew J. Oler, et al. (+47)
36 [GO] 2022―Jun―21 Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling Leila B. Giron, Michael J. Peluso, Jianyi Ding, Grace Kenny, Netanel F. Zilberstein, Jane Koshy, et al. (+23)
37 [GO] 2022―Jun―21 Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, Pamela C. Cai, Elizabeth B. Burgener, Nadine Nagy, et al. (+20)
38 [GO] 2022―Jun―21 Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA-vaccinated patients with inflammatory bowel disease Kathryn A. Pape, Thamotharampillai Dileepan, William E. Matchett, Charles Ellwood, Samuel Stresemann, Amanda J. Kabage, et al. (+14)
39 [GO] 2022―Jun―02 mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primates Adam T. Waickman, Kaitlin Victor, Krista Newell, Tao Li, Heather Friberg, Kathryn E. Foulds, et al. (+4)
40 [GO] 2022―May―24 Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses Anna L. McNaughton, Robert S. Paton, Matthew Edmans, Jonathan C.W. Youngs, Judith Wellens, Prabhjeet Phalora, et al. (+48)
41 [GO] 2022―May―17 Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination Yusuke Matsui, Lin Li, Mary Prahl, Arianna G. Cassidy, Nida Ozarslan, Yarden Golan, et al. (+29)
42 [GO] 2022―May―17 Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model Kyle Rosenke, Atsushi Okumura, Matthew C. Lewis, Friederike Feldmann, Kimberly Meade-White, William F. Bohler, et al. (+5)
43 [GO] 2022―May―10 Phase 1 trial of cyclosporine for hospitalized patients with COVID-19 Emily A. Blumberg, Julia Han Noll, Pablo Tebas, Joseph A. Fraietta, Ian Frank, Amy E. Marshall, et al. (+17)
44 [GO] 2022―Apr―28 Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination Tarani Kanta Barman, Amit K. Singh, Jesse L. Bonin, Tanvir N. Nafiz, Sharon L. Salmon, Dennis W. Metzger
45 [GO] 2022―Apr―26 JAK inhibitor blocks COVID-19-cytokine-induced JAK-STAT-APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids Sarah E. Nystrom, Guojie Li, Somenath Datta, Karen Soldano, Daniel Silas, Astrid Weins, et al. (+3)
46 [GO] 2022―Apr―26 Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases Roya M. Dayam, Jaclyn C. Law, Rogier L. Goetgebuer, Gary Y.C. Chao, Kento T. Abe, Mitchell Sutton, et al. (+26)
47 [GO] 2022―Apr―21 Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19 Michael Chait, Mine M. Yilmaz, Shanila Shakil, Amy W. Ku, Pranay Dogra, Thomas J. Connors, et al. (+12)
48 [GO] 2022―Apr―21 Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice Bao-Zhong Zhang, Huiping Shuai, Hua-rui Gong, Jing-Chu Hu, Bingpeng Yan, Terrence Tsz-Tai Yuen, et al. (+19)
49 [GO] 2022―Apr―19 Longitudinal analysis of T-cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, H. Jabran Zahid, Cara L. Carty, Rebecca Elyanow, et al. (+23)
50 [GO] 2022―Apr―19 T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, et al. (+16)
51 [GO] 2022―Apr―07 Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2 Aleksei Titov, Regina Shaykhutdinova, Olga V. Shcherbakova, Yana V. Serdyuk, Savely A. Sheetikov, Ksenia V. Zornikova, et al. (+17)
52 [GO] 2022―Apr―07 SARS-CoV-2 -specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge Bezawit A. Woldemeskel, Caroline C. Garliss, Tihitina Y. Aytenfisu, Trevor S. Johnston, Evan J. Beck, Arbor G. Dykema, et al. (+9)
53 [GO] 2022―Apr―07 Role of antibodies, inflammatory markers, and echocardiographic findings in post-acute cardiopulmonary symptoms after SARS-CoV-2 infection Matthew S. Durstenfeld, Michael J. Peluso, J. Daniel Kelly, Sithu Win, Shreya Swaminathan, Danny Li, et al. (+18)
54 [GO] 2022―Apr―05 Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients Elisa Brauns, Abdulkader Azouz, David Grimaldi, Hanxi Xiao, Séverine Thomas, Muriel Nguyen, et al. (+11)
55 [GO] 2022―Mar―29 IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function Livia Casciola-Rosen, David R. Thiemann, Felipe Andrade, Maria I. Trejo-Zambrano, Elissa K. Leonard, Jamie B. Spangler, et al. (+32)
56 [GO] 2022―Mar―29 Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients Eva Schrezenmeier, Hector Rincon-Arevalo, Annika Jens, Ana-Luisa Stefanski, Charlotte Hammett, Bilgin Osmanodja, et al. (+23)
57 [GO] 2022―Mar―22 Binding and neutralizing antibody responses to SARS-CoV-2 in young children exceed those in adults Ruth A. Karron, Maria Garcia Quesada, Elizabeth A. Schappell, Stephen D. Schmidt, Maria Deloria Knoll, Marissa K. Hetrich, et al. (+3)
58 [GO] 2022―Mar―17 RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19 Katherine D. Wick, Lianne Siegel, James D. Neaton, Cathryn Oldmixon, Jens Lundgren, Robin L. Dewar, et al. (+3)
59 [GO] 2022―Mar―15 Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, Chia-Yi Yu, Yu-Ling Huang, Hung-Chun Liao, et al. (+3)
60 [GO] 2022―Mar―01 In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individuals Li Li, Muharrem Muftuoglu, Shaoheng Liang, Mahesh Basyal, Jiangxing LV, Mehmet E. Akdogan, et al. (+3)
61 [GO] 2022―Feb―22 Durability of ChAdOx1 nCov-19 vaccination in people living with HIV Ane Ogbe, Matthew Pace, Mustapha Bittaye, Timothy Tipoe, Sandra Adele, Jasmini Alagaratnam, et al. (+52)
62 [GO] 2022―Feb―21 Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations Tian Tian, Jinfeng Wu, Tao Chen, Jia Li, Su Yan, Yiran Zhou, et al. (+10)
63 [GO] 2022―Feb―17 Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19 Xinge Wang, Mark A. Sanborn, Yang Dai, Jalees Rehman
64 [GO] 2022―Feb―08 T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components Lichen Jing, Xia Wu, Maxwell P. Krist, Tien-Ying Hsiang, Victoria L. Campbell, Christopher L. McClurkan, et al. (+13)
65 [GO] 2022―Feb―08 Disulfiram inhibits neutrophil extracellular trap formation protecting rodents from acute lung injury and SARS-CoV-2 infection Jose M. Adrover, Lucia Carrau, Juliane Daßler-Plenker, Yaron Bram, Vasuretha Chandar, Sean Houghton, et al. (+7)
66 [GO] 2022―Feb―01 Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection Han-Sol Park, Janna R. Shapiro, Ioannis Sitaras, Bezawit A. Woldemeskel, Caroline Garliss, Amanda Dziedzic, et al. (+32)
67 [GO] 2022―Jan―24 Impairing RAGE signaling promotes survival and limits disease pathogenesis following SARS-CoV-2 infection in mice Forrest Jessop, Benjamin Schwarz, Dana Scott, Lydia M. Roberts, Eric Bohrnsen, John R. Hoidal, Catharine M. Bosio
68 [GO] 2022―Jan―19 Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared to COVID-19 Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna M. Horner, Alyssa Brooks, Lisa Macoy, et al. (+10)
69 [GO] 2022―Jan―14 Multiple sclerosis therapies differentially impact SARS-CoV-2 vaccine-induced antibody and T cell immunity and function Joseph J. Sabatino Jr, Kristen Mittl, William M. Rowles, Kira McPolin, Jayant V. Rajan, Matthew T. Laurie, et al. (+14)
70 [GO] 2022―Jan―12 SARS-CoV-2 BNT162b2 vaccine-induced humoral response and reactogenicity in individuals with prior COVID-19 disease Steven G. Kelsen, Alan S. Braverman, Mark O. Aksoy, Jacob A. Hayman, Puja S. Patel, Charu Rajput, et al. (+4)
71 [GO] 2021―Dec―21 Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine Suhas Sureshchandra, Sloan A. Lewis, Brianna M. Doratt, Allen Jankeel, Izabela Coimbra Ibraim, Ilhem Messaoudi
72 [GO] 2021―Dec―15 A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies Rachita Panda, Fernanda V.S. Castanheira, Jared M. Schlechte, Bas G.J. Surewaard, Hanjoo Brian Shim, Amanda Z. Zucoloto, et al. (+4)
73 [GO] 2021―Dec―14 Clinico-histopathologic and single nuclei RNA sequencing insights into cardiac injury and microthrombi in critical COVID-19 Michael I. Brener, Michelle L. Hulke, Nobuaki Fukuma, Stephanie Golob, Robert S. Zilinyi, Zhipeng Zhou, et al. (+19)
74 [GO] 2021―Dec―06 Duration of viral shedding and culture positivity with post-vaccination SARS-CoV-2 delta variant infections Mark J. Siedner, Julie Boucau, Rebecca F. Gilbert, Rockib Uddin, Jonathan Luu, Sebastien Haneuse, et al. (+14)
75 [GO] 2021―Nov―22 Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties Ryan P. Bennett, Elena N. Postnikova, Brett P. Eaton, Yingyun Cai, Shuiqing Yu, Charles O. Smith, et al. (+6)
76 [GO] 2021―Nov―18 Atypical response to bacterial co-infection and persistent neutrophilic broncho-alveolar inflammation distinguish critical COVID-19 from influenza Seppe Cambier, Mieke Metzemaekers, Ana C. Carvalho, Amber Nooyens, Cato Jacobs, Lore Vanderbeke, et al. (+15)
77 [GO] 2021―Nov―12 Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations Louisa Helms, Silvia Marchiano, Ian B. Stanaway, Tien-Ying Hsiang, Benjamin A. Juliar, Shally Saini, et al. (+16)
78 [GO] 2021―Nov―07 Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19 Suchitra Kamle, Bing Ma, Chuan Hua He, Bedia Akosman, Yang Zhou, Chang-Min Lee, et al. (+9)
79 [GO] 2021―Nov―03 SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements Jez L. Marston, Matthew Greenig, Manvendra Singh, Matthew L. Bendall, Rodrigo R.R. Duarte, Cédric Feschotte, et al. (+2)
80 [GO] 2021―Oct―19 Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, et al. (+24)
81 [GO] 2021―Oct―07 Human nasal wash RNA-seq reveals distinct cell-specific innate immune responses between influenza and SARS-CoV-2 Kevin M. Gao, Alan G. Derr, Zhiru Guo, Kerstin Nundel, Ann Marshak-Rothstein, Robert W. Finberg, Jennifer P. Wang
82 [GO] 2021―Sep―10 Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19 Alec A. Schmaier, Gabriel M. Pajares Hurtado, Zachary J. Manickas-Hill, Kelsey D. Sack, Siyu M. Chen, Victoria Bhambhani, et al. (+11)
83 [GO] 2021―Sep―10 More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals Sabrina E. Racine-Brzostek, Jim K. Yee, Ashley Sukhu, Yuqing Qiu, Sophie Rand, Paul D. Barone, et al. (+10)
84 [GO] 2021―Aug―31 Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2 transgenic mice Masamitsu N. Asaka, Daichi Utsumi, Haruhiko Kamada, Satoshi Nagata, Yutaka Nakachi, Tomokazu Yamaguchi, et al. (+3)
85 [GO] 2021―Aug―27 A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity Annemieke Smet, Tom Breugelmans, Johan Michiels, Kevin Lamote, Wout Arras, Joris G. De Man, et al. (+16)
86 [GO] 2021―Aug―17 Self-sustaining interleukin-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19 Rainer Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, et al. (+24)
87 [GO] 2021―Aug―17 Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long-COVID John P. Haran, Evan Bradley, Abigail L. Zeamer, Lindsey Cincotta, Marie-Claire Salive, Protiva Dutta, et al. (+7)
88 [GO] 2021―Aug―10 SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8 Valentina Salvi, Hoang Oanh Nguyen, Francesca Sozio, Tiziana Schioppa, Carolina Gaudenzi, Mattia Laffranchi, et al. (+11)
89 [GO] 2021―Aug―06 Ex vitro SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses Matthew A. Schaller, Yamini Sharma, Zadia Dupee, Duy T. Nguyen, Juan M. Urueña, Ryan A. Smolchek, et al. (+7)
90 [GO] 2021―Jul―27 COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction Kimberly A. Queisser, Rebecca A. Mellema, Elizabeth A. Middleton, Irina Portier, Bhanu Kanth Manne, Frederik Denorme, et al. (+4)
91 [GO] 2021―Jul―21 L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus Yuji Kondo, Jason L. Larabee, Liang Gao, Huiping Shi, Bojing Shao, Christopher M. Hoover, et al. (+15)
92 [GO] 2021―Jul―20 Nucleocapsid-specific and PD-L1+CXCR3+ CD8 polyfunctional T-cell abundances are associated with survival of critical SARS-CoV2-infected patients Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, et al. (+8)
93 [GO] 2021―Jul―12 Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay Ester Lopez, Ebene R. Haycroft, Amy Adair, Francesca L. Mordant, Matthew T. O'Neill, Phillip Pymm, et al. (+15)
94 [GO] 2021―Jul―12 HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells Rabiah Fardoos, Osaretin E. Asowata, Nicholas Herbert, Sarah K. Nyquist, Yenzekile Zungu, Alveera Singh, et al. (+14)
95 [GO] 2021―Jul―09 SARS-CoV-2 infection of the pancreas promotes thrombo-fibrosis and is associated with new-onset diabetes Mirza Muhammad Fahd Qadir, Manika Bhondeley, Wandy Beatty, Dina D. Gaupp, Lara A. Doyle-Meyers, Tracy Fischer, et al. (+9)
96 [GO] 2021―Jul―08 Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration Sigrid Gouma, Madison E. Weirick, Marcus J. Bolton, Claudia P. Arevalo, Eileen C. Goodwin, Elizabeth M. Anderson, et al. (+12)
97 [GO] 2021―Jul―06 Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, et al. (+13)
98 [GO] 2021―Jun―29 IL-13 is a driver of COVID-19 severity Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, Saskia Preissner, Benjamin T. Bradley, Rebecca M. Carpenter, et al. (+21)
99 [GO] 2021―Jun―24 Autoantibodies stabilize neutrophil extracellular traps in COVID-19 Yu Zuo, Srilakshmi Yalavarthi, Sherwin A. Navaz, Claire K. Hoy, Alyssa Harbaugh, Kelsey Gockman, et al. (+5)
100 [GO] 2021―Jun―18 COVID-19 and RA share SPP1 myeloid pathway that drives PD-L1pos neutrophils and CD14pos monocytes Lucy MacDonald, Stefano Alivernini, Barbara Tolusso, Aziza Elmesmari, Domenico Somma, Simone Perniola, et al. (+20)
101 [GO] 2021―Jun―18 Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses Jacob K. Files, Sanghita Sarkar, Timothy R Fram., Sushma Boppana, Sarah Sterrett, Kai Qin, et al. (+6)
102 [GO] 2021―Jun―10 Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 Hyung J. Chun, Elias Coutavas, Alexander B. Pine, Alfred I. Lee, Vanessa L. Yu, Marcus K. Shallow, et al. (+6)
103 [GO] 2021―Jun―03 Epitope-specific antibody responses differentiate COVID-19 outcome and variants of concern Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Ackloo, Tomonori Kaneko, et al. (+20)
104 [GO] 2021―Jun―01 Cardiovascular complications of COVID-19 Farnaz Farshidfar, Navid Koleini, Hossein Ardehali
105 [GO] 2021―May―23 The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age Paula P. Freire, Alexandre H.C. Marques, Gabriela C. Baiocchi, Lena F. Schimke, Dennyson L.M. Fonseca, Ranieri C. Salgado, et al. (+17)
106 [GO] 2021―May―11 Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2 Reut Falach, Liat Bar-On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, et al. (+24)
107 [GO] 2021―May―09 A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients Samantha M. Morrissey, Anne E. Geller, Xiaoling Hu, David Tieri, Chuanlin Ding, Christopher K. Klaes, et al. (+19)
108 [GO] 2021―Apr―28 Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques Yongjun Sui, Jianping Li, Roushu Zhang, Sunaina Kiran Prabhu, Hanne Andersen Elyard, David Venzon, et al. (+19)
109 [GO] 2021―Apr―22 Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus Ami Patel, Emma L. Reuschel, Ziyang Xu, Faraz I. Zaidi, Kevin Y. Kim, Dana P. Scott, et al. (+17)
110 [GO] 2021―Apr―06 Natural mucosal barriers and COVID-19 in children Carl A. Pierce, Sharlene Sy, Benjamin Galen, Doctor Y. Goldstein, Erika P. Orner, Marla J. Keller, et al. (+2)
111 [GO] 2021―Apr―06 SARS-CoV-2 vaccines: a triumph of science and collaboration Jonathan L. Golob, Njira Lugogo, Adam S. Lauring, Anna S. Lok
112 [GO] 2021―Mar―23 Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure Alexis R. Demonbreun, Thomas W. McDade, Lorenzo L. Pesce, Lauren A. Vaught, Nina L. Reiser, Elena Bogdanovic, et al. (+11)
113 [GO] 2021―Mar―21 Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area Peter M. Thielen, Shirlee Wohl, Thomas Mehoke, Srividya Ramakrishnan, Melanie Kirsche, Oluwaseun Falade-Nwulia, et al. (+16)
114 [GO] 2021―Mar―15 A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2 Abdelilah Majdoubi, Christina Michalski, Sarah E. O’Connell, Sarah Dada, Sandeep R. Narpala, Jean P. Gelinas, et al. (+17)
115 [GO] 2021―Mar―02 Cell-free DNA maps COVID-19 tissue injury and risk of death, and can cause tissue injury Temesgen E. Andargie, Naoko Tsuji, Fayaz Seifuddin, Moon Kyoo Jang, Peter S.T. Yuen, Hyesik Kong, et al. (+9)
116 [GO] 2021―Feb―27 Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2 Krystle K.Q. Yu, Stephanie Fischinger, Malisa T. Smith, Caroline Atyeo, Deniz Cizmeci, Caitlin R. Wolf, et al. (+15)
117 [GO] 2021―Feb―11 Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma Michele L. Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, et al. (+42)
118 [GO] 2021―Feb―02 Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2 Lotfi Chouchane, Jean-Charles Grivel, Elmoubasher Farag, Igor Pavlovski, Selma Maacha, Abbirami Sathappan, et al. (+11)
119 [GO] 2021―Jan―26 Distinct antibody repertoires against endemic human coronaviruses in children and adults Taushif Khan, Mahbuba Rahman, Fatima Al Ali, Susie S.Y. Huang, Manar Ata, Qian Zhang, et al. (+19)
120 [GO] 2021―Jan―21 Rectifying COVID-19 disparities with treatment and vaccination John M. Carethers
121 [GO] 2021―Jan―21 Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors Yang Han, Peipei Liu, Yang Qiu, Jie Zhou, Ying Liu, Xujuan Hu, et al. (+13)
122 [GO] 2021―Jan―21 Treatment of Severe COVID-19 with Convalescent Plasma in Bronx, NYC Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, et al. (+49)
123 [GO] 2021―Jan―14 Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 Davide Scozzi, Marlene Cano, Lina Ma, Dequan Zhou, Ji Hong Zhu, Jane A. O’Halloran, et al. (+15)
124 [GO] 2021―Jan―10 Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022 Caroline Atyeo, Matthew D. Slein, Stephanie Fischinger, John Burke, Alexandra Schäfer, Sarah R. Leist, et al. (+20)
125 [GO] 2020―Dec―07 Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2 induced systemic toxicity Shen Li, Feiyang Ma, Tomohiro Yokota, Gustavo Garcia Jr., Amelia Palermo, Yijie Wang, et al. (+18)
126 [GO] 2020―Nov―24 An immune-based biomarker signature is associated with mortality in COVID-19 patients Michael S. Abers, Ottavia M. Delmonte, Emily E. Ricotta, Jonathan Fintzi, Danielle Fink, Adriana A. de Jesus, et al. (+40)
127 [GO] 2020―Oct―22 Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models Kyle Rosenke, Michael A. Jarvis, Friederike Feldmann, Benjamin Schwarz, Atsushi Okumura, Jamie Lovaglio, et al. (+17)
128 [GO] 2020―Oct―09 Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors Cong Zeng, John P. Evans, Rebecca Pearson, Panke Qu, Yi-Min Zheng, Richard T. Robinson, et al. (+8)
129 [GO] 2020―Sep―16 High levels of SARS-CoV-2 specific T-cells with restricted functionality in severe course of COVID-19 David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp M. Lepper, Heinrike Wilkens, et al. (+7)
130 [GO] 2020―Sep―01 A simple protein-based surrogate neutralization assay for SARS-CoV-2 Kento T. Abe, Zhijie Li, Reuben Samson, Payman Samavarchi-Tehrani, Emelissa J. Valcourt, Heidi Wood, et al. (+17)
131 [GO] 2020―Aug―25 Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease Joseph W. Golden, Curtis R. Cline, Xiankun Zeng, Aura R. Garrison, Brian D. Carey, Eric M. Mucker, et al. (+11)
132 [GO] 2020―Aug―14 Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity Kathleen M. McAndrews, Dara P. Dowlatshahi, Jianli Dai, Lisa M. Becker, Janine Hensel, Laura M. Snowden, et al. (+13)
133 [GO] 2020―Jul―24 Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel A. Roque, Adijat Asuni, et al. (+9)
134 [GO] 2020―Jul―20 Severe immunosuppression and not a cytokine storm characterize COVID-19 infections Kenneth E. Remy, Monty Mazer, David A. Striker, Ali H. Ellebedy, Andrew H. Walton, Jacqueline Unsinger, et al. (+15)
135 [GO] 2020―Jun―19 COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, Travis Nemkov, Lorenzo Bertolone, Richard O. Francis, et al. (+6)
136 [GO] 2020―Jun―18 The complement system in COVID-19: friend and foe? Anuja Java, Anthony J. Apicelli, M. Kathryn Liszewski, Ariella Coler-Reilly, John P. Atkinson, Alfred H.J. Kim, Hrishikesh S. Kulkarni
137 [GO] 2020―Jun―16 IL-6 combined with CD8+ T cell count early predict in-hospital mortality for patients with COVID-19 Miao Luo, Jing Liu, Weiling Jiang, Shuang Yue, Huiguo Liu, Shuang Wei
138 [GO] 2020―Jun―12 New (re)Purpose for an old drug: purinergic receptor blockade may extinguish the COVID-19 thrombo-inflammatory firestorm Yogendra Kanthi, Jason S. Knight, Yu Zuo, David J. Pinsky
139 [GO] 2020―Jun―05 Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease Yan Zhao, Ling Qin, Ping Zhang, Kang Li, Lianchun Liang, Jianping Sun, et al. (+16)
140 [GO] 2020―May―19 Clinical and pathological investigation of severe COVID-19 patients Shaohua Li, Lina Jiang, Xi Li, Fang Lin, Yijin Wang, Boan Li, et al. (+17)
141 [GO] 2020―May―07 Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens Jun Liu, April M. Babka, Brian J. Kearney, Sheli R. Radoshitzky, Jens H. Kuhn, Xiankun Zeng
142 [GO] 2020―Apr―30 Characteristics and diagnosis rate of 5,630 subjects receiving SARS-CoV-2 nucleic acid tests from Wuhan, China Na Shen, Yaowu Zhu, Xiong Wang, Jing Peng, Weiyong Liu, Feng Wang, et al. (+3)
143 [GO] 2020―Apr―24 Neutrophil extracellular traps in COVID-19 Yu Zuo, Srilakshmi Yalavarthi, Hui Shi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, et al. (+7)
144 [GO] 2020―Apr―23 The laboratory tests and host immunity of COVID-19 patients with different severity of illness Feng Wang, Hongyan Hou, Ying Luo, Guoxing Tang, Shiji Wu, Min Huang, et al. (+7)
145 [GO] 2020―Apr―17 COVID-19 in older adults: clinical, psychosocial, and public health considerations John P. Mills, Keith S. Kaye, Lona Mody
 [1] 

145 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.017 sec